相关实验视频
Updated: Jul 11, 2025

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
经过透管大动脉植入后,心脏起器依赖和导电系统恢复
Joseph Cosma1,2, Alessandro Russo3, Sofia Schino3
1Department of Cardiology, Tor Vergata University, Rome, Italy - josephcosma1990@gmail.com.
Minerva cardiology and angiology
|November 16, 2023
概括
通过导管的大动脉植入可以导致导电问题. 在基线心电图上延长PR间隔和右束分支块预测TAVI后心脏起器依赖性,尽管许多患者康复.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 电子生理学 电子生理学
背景情况:
- 过导管大动脉植入 (TAVI) 可能导致导电系统障碍.
- 这些疾病可能会随着时间的推移自发地消失.
- 预测TAVI后的永久心脏起器 (PPM) 依赖性对于患者管理至关重要.
研究的目的:
- 为了确定预测TAVI后患者永久心脏起器 (PPM) 依赖的因素.
- 评估12个月后的传导障碍和PPM依赖的解决率.
主要方法:
- 研究了一组37名需要在TAVI六天内植入PPM的患者.
- 在12个月的随访中,患者被分为PPM依赖和非PPM依赖的组.
- 分析了基线心电图参数和临床特征.
主要成果:
- PPM依赖性从植入时的62.2%下降到12个月后的35.1%.
- 在基线心电图上,PPM依赖的重要预测因素包括延长的PR间隔 (P=0.003) 和右束分支块 (RBBB) (P=0.02) 的存在.
- 持久性心房阻塞 (AVB) 和交替捆绑分支阻塞 (BBB) 在依赖PPM的组中更常见.
结论:
- 在TAVI后12个月,PPM依赖程度显著降低.
- 基线PR间隔和RBBB是长期PPM依赖的关键预测指标.
- 在没有持续的AVB或交替的BBB的患者中,建议对导电恢复进行仔细评估,特别是如果基线心电图显示正常的PR间隔和没有RBBB.
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiac Catheterization IV: Nursing Management
29
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
29
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Cardiomyopathy VII: Pre and Post Operative Nursing Management
15
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18

